Pesquisas alternativas:
does » dos (Expandir a Pesquisa)
devel » level (Expandir a Pesquisa), devem (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
live » liv (Expandir a Pesquisa), line (Expandir a Pesquisa), like (Expandir a Pesquisa)
does » dos (Expandir a Pesquisa)
devel » level (Expandir a Pesquisa), devem (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
live » liv (Expandir a Pesquisa), line (Expandir a Pesquisa), like (Expandir a Pesquisa)
1
“... markedly negative impact on the sufferer’s quality of life. Following conservative and lifestyle management...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... are constantly under pressure, higher percentages of drugs are demanded, and the drug-discovery process is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
4
“...AIMS: Drug and alcohol use-related stigma affects employment, physical and mental health, and has...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
8
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“..., BMI, drug dose and time from drug intake were recorded. RESULTS: All patients had a measurable...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...The development of antibody-drug conjugates (ADCs), a promising class of anti-cancer agents, has...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
13
Por Kosilov, Kirill Vladimirovich, Loparev, Sergey, Kuzina, Irina, Shakirova, Olga, Zhuravskaya, Nataliya, Lobodenko, Alexandra
Publicado no Ther Adv Urol (2016)
“... in antimuscarinic (AM) drug treatment. BACKGROUND: The prevalence of urge urinary incontinence (UUI) is an average...”Publicado no Ther Adv Urol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Erkılıç, E, Kesimci, E, Alaybeyoğlu, F, Kılınç, I, Tural, R, Yazgan, A, Gümüş, T, Sepici Dinçel, A, Dumlu, EG, Kanbak, O
Publicado no Drug Des Devel Ther (2017)
Obter o texto integralPublicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Artigo
15
16
“... response, lower the risk that drug resistance will develop, and reduce morbidity and mortality. Little...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Djobet, M. P. Ngogang, Singhe, David, Lohoue, Julienne, Kuaban, Christopher, Ngogang, Jeanne, Tambo, Ernest
Publicado no AIDS Res Ther (2017)
“.... ARVs drugs samples included Nevirapine, Efavirenz, and fixed dose combinations of Zidovudine...”Publicado no AIDS Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Vornov, James J., Wozniak, Krystyna M., Wu, Ying, Rojas, Camilo, Rais, Rana, Slusher, Barbara S.
Publicado em 2013
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Goláň, Lubor, Goker-Alpan, Ozlem, Holida, Myrl, Kantola, Ikka, Klopotowski, Mariusz, Kuusisto, Johanna, Linhart, Aleš, Musial, Jacek, Nicholls, Kathleen, Gonzalez-Rodriguez, Derlis, Sharma, Reena, Vujkovac, Bojan, Chang, Peter, Wijatyk, Anna
Publicado no Drug Des Devel Ther (2015)
“.... Secondary endpoints included cardiac (peak oxygen consumption, 6-minute walk test, Minnesota Living...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Wang, Xue Yan, Lim-Jurado, Margaret, Prepageran, Narayanan, Tantilipikorn, Pongsakorn, Wang, De Yun
Publicado no Ther Clin Risk Manag (2016)
“... that it has very low potential for drug–drug interactions, and does not require dose adjustment in renal...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo